Population pharmacokinetics of nirmatrelvir/ritonavir in critically ill Chinese COVID-19 patients and recommendations for medication use: a two-center retrospective study
PPK modeling and simulation provided a reference for the rational clinical application of nirmatrelvir/ritonavir in critically ill Chinese patients.
Authors
- Xudong Fan (ORCID: https://orcid.org/0000-0001-6531-9694)
- Yangmin Hu
- Haili Shan
- Yichao Xu (ORCID: https://orcid.org/0000-0002-0476-9787)
- Haibin Dai (ORCID: https://orcid.org/0000-0002-5768-2714)
- Meng Chen (ORCID: https://orcid.org/0000-0003-3525-875X)
- Xinjun Cai (ORCID: https://orcid.org/0000-0003-3606-8819)
- Junjun Xu (ORCID: https://orcid.org/0000-0002-0687-8100)
- Jinmeng Li (ORCID: https://orcid.org/0000-0001-6589-3610)
- Huifang Jiang (ORCID: https://orcid.org/0009-0001-1772-0659)
- Yuying Lang
- Mingdong Yang (ORCID: https://orcid.org/0000-0002-9656-0365)
Institutions
- Zhejiang Hospital (CN)
- Hangzhou Red Cross Hospital (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
Publication Details
- Journal
- Expert Review of Clinical Pharmacology
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1080/17512433.2024.2410385
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 0.00